Mon, Jul 28, 2014, 1:11 AM EDT - U.S. Markets open in 8 hrs 19 mins

Recent

% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Apr 18, 2013 11:04 AM Flag

    Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

    $$$$
    Currently #24 of 43 (!!!!) at clinicaltrialsdotgov...
    A relatively large p2 NCI-sponsored trial, enrolling 150...presumably in addition to the RCC trial EXEL is planning later this year. I haven't but barely glanced at the other new trial announcements, but we've gained another 10% in clinical mojo this week alone!!!
    GLTA

 
EXEL
4.19-0.02(-0.48%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.